COMP <GO>
ECG vs CVCO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Everus Construction Group Inc. (NYSE) VS. Cavco Industries Inc. (NASDAQ) • 15-METRIC TALLY: ECG 5
— CVCO 8
■ METRIC PARITY
LAST: $102.99 (+0.35%) • MKT CAP: $5.24B
options-implied-move
—
LAST: $662.89 (+7.09%) • MKT CAP: $4.76B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. CVCO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | CVCO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 23.50% | -11.40 | CVCO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 17.60% | +12.80 | ECG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 16.0x | -2.30 | ECG | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | 5.52% | -5.73 | CVCO | /fcf-yield <GO> |
| Operating Margin | 7.10% | 10.20% | -3.10 | CVCO | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 8.50% | -3.10 | CVCO | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | 11.40% | +20.10 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 10.31 | -3.84 | CVCO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | CVCO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.7 | 61.9 | -20.20 | CVCO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 0.93 | +0.20 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 20.5x | +2.40 | CVCO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.24B | $4.76B | $480.9M | ECG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | CVCO REV | ECG GROSS % | CVCO GROSS % | ECG FCF | CVCO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.75B | $2.24B | 12.1% | 23.5% | -$11.7M | $232.1M |
| FY 2024 | $2.85B | $2.02B | 11.9% | 23.1% | $35.1M | $157.1M |
| FY 2023 | $2.85B | $1.79B | — | — | $42.9M | $143.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
CVCO // BETA 0.93